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Abstract: South Asians (i.e., people who originate from India, Pakistan, Sri Lanka, Nepal, and
Bangladesh) have higher cardiovascular disease rates than other populations, and these differ-
ences persist in their offspring. Nutrition is a critical lifestyle-related factor that influences fetal
development, and infant and child health in early life. In high-income countries such as Canada,
nutrition-related health risks arise primarily from overnutrition, most strikingly for obesity and
associated non-communicable diseases. Evidence for developmental programming during fetal
life underscores the critical influence of maternal diet on fetal growth and development, backed
by several birth cohort studies including the Pune Maternal Nutrition Study, the South Asian Birth
Cohort Study, and the Born in Bradford Study. Gestational diabetes mellitus is a strong risk factor for
type 2 diabetes, future atherosclerosis and cardiovascular disease in the mother and increases the
risk of type 2 diabetes in her offspring. Non-pharmacological trials to prevent gestational diabetes
are few, often not randomized, and are heterogeneous with respect to design, and outcomes have
not converged upon a single optimal prevention strategy. The aim of this review is to provide an
understanding of the current knowledge around perinatal nutrition and gestational diabetes among
the high-risk South Asian population as well as summarize our research activities investigating the
role of culturally-tailored nutrition advice to South Asian women living in high-income settings such
as Canada. In this paper, we describe these qualitative and quantitative studies, both completed and
underway. We conclude with a description of the design of a randomized trial of a culturally tailored
personalized nutrition intervention to reduce gestational glycaemia in South Asian women living in
Canada and its implications.
Keywords: perinatal; South Asians; nutrition; infant and child health; maternal health; healthy active
living; gestational diabetes; culturally-tailored advice; prospective cohort; randomized control trial
1. Introduction
As of 2016 in Canada, >1.9 million people (5.4% of the population) were of South
Asian (SA) ancestry—i.e., people who originate from India, Pakistan, Sri Lanka, Nepal, and
Bangladesh—comprising the largest visible minority group in Canada (25.6%) [1]. This
number is projected to reach approximately 4.1 million by 2036, of which nearly 1 million
will be women of child-bearing age [2]. Evidence collected over the last 20 years suggests
that cardiovascular disease (CVD) rates in SAs are higher than other ethnic groups living in
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Canada [3–6], and, among SAs, CVD is more severe, presents at younger ages, and in some
contexts, this is due to differential access to diagnostic and treatment services compared to
non-SAs [7–9]. The etiology of this elevated risk for CVD in SAs is not fully understood
but early life fetal and childhood exposures have been proposed as major determinants.
The aim of this review is to provide an understanding of the current knowledge
around perinatal nutrition and gestational diabetes among the high-risk South Asian
population as well as summarize work investigating the role of culturally tailored nutrition
advice to South Asian women living in high-income settings like Canada. We begin with
describing these qualitative and quantitative studies, both completed and underway, and
conclude with a description of the design of a randomized trial of a culturally-tailored
personalized nutrition intervention to reduce gestational glycaemia in South Asian women
living in Canada and its implications.
2. Early Life Determinants of CVD
The “Barker hypothesis” proposed in 1990 by epidemiologist David Barker (1938–2013)
posits that in humans, intrauterine growth retardation, low birth weight, and premature
birth have a causal relationship with the origins of hypertension, type 2 diabetes, and
coronary heart disease in adulthood [10]. One long-term consequence of inadequate early
nutrition is the impaired development of the endocrine pancreas, which thereafter makes
the infant nutritionally “thrifty”. If the post-natal environment is nutritionally deprived, the
phenotype is advantageous, but if the same infant is exposed to a high-nutrition post-natal
environment, the result may be increased cardiometabolic risk [11].
Two observations provided the impetus for the development of Barker’s hypothesis.
Barker and Osmond reported a positive association between a county’s neonatal death rate
(a surrogate for low birth weight (LBW) and its cardiovascular mortality rate [12]. In 1989,
Barker revisited Hertfordshire County birth records from 1911 to assess the association
between birth weight and ischemic heart disease and found that LBW babies had three
times the rate of ischemic heart disease as normal-weight babies [10,13].
Children who experience intrauterine growth retardation experience higher risk of
coronary heart disease (CHD), some of whom experience catch-up growth early in life.
To examine whether catch-up growth during childhood modifies the increased risk of
death from CHD associated with reduced intrauterine growth, Eriksson et al. followed
3641 boys from birth through adulthood to assess the association between birth weight and
death from CHD, in the context of catch-up growth [14]. Men who died from CHD had an
above average body mass index at all ages from 7 to 15 years. They found that those who
were born large but were small at age 11 were at no increased risk of adult CHD, whereas
those who were born small and experienced large catch-up growth were at the highest
risk of death from CHD later in adulthood. The highest death rates from CHD occurred
in boys who were thin at birth, but whose weight caught up with the result of an average
or > average body mass from the age of 7 years onwards [14].
The Dutch Hunger Winter occurred in West Netherlands near the end of World War 2
when food rations were limited to fewer than 800 kcal/d [15,16]. In a historical cohort
study, 300,000 19-year-old men whose mothers were exposed to the Dutch Hunger Winter
pre- and post-natally were examined at military induction to test the hypothesis that
prenatal and early postnatal nutrition determines subsequent obesity [17]. The influence of
maternal exposure to the famine was highly dependent on the timing. Exposure to famine
during the last trimester of pregnancy and the first months of life produced significantly
lower obesity rates and better glucose tolerance. This is consistent with the inference
that nutritional deprivation affected a critical period of development for adipose-tissue
cellularity. Exposure to famine during the first half of pregnancy, however, resulted in
significantly higher obesity rates and poorer glucose tolerance. These data are supported
by additional famine studies from China, Ukraine, and Austria but not those from the
former Soviet Union or those undertaken in Africa [18–21].
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Nutrition is a critical lifestyle-related factor that influences the development of the
fetus before birth and infant and child health in early life. In low-income countries, health
risks are primarily due to undernutrition, while in high-income countries such as Canada,
nutrition-related health risks arise primarily from overnutrition (e.g., excess calories), most
strikingly for obesity and associated NCDs [22]. These poor-quality diets can result in the
paradoxical “overfed-undernourished” expectant mothers, and such unbalanced nutrition
is associated with several adverse maternal, infant, and child outcomes. These include ex-
cessive weight gain during pregnancy, gestational diabetes mellitus (GDM), slow or rapid
postnatal growth, infant and childhood adiposity, allergic disorders, and asthma. Data
on developmental activities during fetal life underscore the critical influence of maternal
diet on fetal growth and development. Interactions between genetic and epigenetic factors
(in both mother and fetus), and sub-optimal maternal nutrition, may increase infant sus-
ceptibility to adverse health outcomes like adiposity, metabolic-syndrome-related factors,
allergic disorders, and asthma [23–25]. Furthermore, infant feeding patterns and alterations
in the gut microbiota during early years may accelerate the development of these adverse
health outcomes longitudinally [26–28].
3. Gestational Diabetes and Related Complications to Mother and Offspring
GDM is a condition in which a woman without diabetes develops high blood glucose
levels during pregnancy [29]. There are several proximal and distal complications associ-
ated with GDM for both the mother and her offspring. Women who are diagnosed with
GDM have a higher risk for perinatal complications including hypertension, pre-eclampsia,
polyhydramnios, caesarean section, and shoulder dystocia [30,31]. A French cohort con-
sisting of 796,346 deliveries, including 57,629 women with GDM, showed that the risk for
caesarian section was forty percent higher (OR = 1.4; 95% CI: 1.4, 1.4), while the risk for
pre-eclampsia was seventy percent higher (OR = 1.7, 95% CI: 1.6, 1.7) in women with GDM
compared to those who did not have GDM during pregnancy [32].
Concurrently, the offspring of these women are at a higher risk for macrosomia or
increased fetal size, large for gestational age phenotypes, neonatal hypoglycaemia, preterm
birth, shoulder dystocia, and respiratory distress [30,31]. According to the data from the
French cohort, the odds of such risks are more than double, with the odd for pre-term
birth being thirty percent higher (OR = 1.3; 95% CI: 1.3, 1.4) and the odds for macrosomia
being eighty percent higher (OR = 1.8; 95% CI: 1.7, 1.8) in offspring of women who were
diagnosed with GDM compared to those who did not have GDM during pregnancy [32].
GDM is a strong risk factor for type 2 diabetes (T2DM). Women diagnosed with GDM,
compared to those without, have a seven-fold higher lifetime risk of T2DM, and 50%
of them develop T2DM within five years of giving birth [33–39]. GDM predicts future
atherosclerosis and cardiovascular disease (CVD) in the mother and increases the risk of
T2DM in her offspring up to eight-fold [35–43]. SA women have double the risk of GDM of
white European women. Their offspring also have increased risk factors for future T2DM,
including higher birth weight, more adipose tissue, and reduced insulin sensitivity. These
risk factors are appreciably more common in SA infants born to mothers with GDM than
infants born to mothers without GDM [44]. We have shown that 36.3% of SA women in
Ontario develop GDM [44]. In pregnant SA women, a poor-quality diet during pregnancy
increases the chances of developing GDM (odds ratio [OR]: 1.62; 95% CI: 1.20 to 2.19) [44].
Indeed, the finding that ≈13% of GDM cases in this population could be prevented if
diet quality was not poor (population attributable risk [PAR:]: 12.8%) [44] highlights the
preventive value of an intrapartum dietary intervention to reduce GDM [42,43]. Improving
diet quality in the Canadian population of SA pregnant women may therefore prevent
up to 6500 new T2DM cases by 2031 [2,44]. The next two sections will highlight current
findings about the role of GDM in newborn and childhood health from observational birth
cohorts as well as interventional studies of SAs.
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4. Birth Cohort Studies for Understanding GDM in South Asian Populations
Birth cohort studies collect information on an individual at or before a person’s birth
and continue to study the same individuals after birth at regular intervals [45]. In these
observational studies, there is no randomization to exposure groups and no attempt to
manipulate exposure status. They vary in sample size from large studies that aim to be
nationally representative to those that are area-based and may enrol many hundreds to
many thousands of participants. Such studies are a great resource when studying early de-
terminants of health. Birth cohorts can be useful in elucidating determinants of health that
originate in utero and can differentiate the impact of these from other exposures accumu-
lated throughout one’s lifespan during other critical windows of exposure (e.g., childhood).
Birth cohorts are a relatively new form of observational studies that originated in response
to the DOHaD hypothesis [46]. Apart from highlighting the risk factors that contribute to
perinatal diseases, birth cohorts can also inform interventions developed to address such
risk factors and improve the long-term health of mothers and their offspring, especially
when accompanied by qualitative studies, as we describe later in the paper.
Several birth cohorts have been established over the last few years, both in In-
dia [47–50] and elsewhere [51,52]. Notable among these looking at perinatal nutrition
are the Pune Maternal Nutrition Study in India, the Born in Bradford (BiB) Cohort [51] in
the United Kingdom, and the South Asian Birth Cohort (START) in Canada [52]. Here we
summarize the findings from these cohorts related to GDM in SA women.
4.1. Pune Maternal Nutrition Study Cohort (PMNS)
The Pune Maternal Nutrition Study (PMNS), one of the largest birth cohorts in India,
was initiated in 1994. Much of the data that has highlighted the importance of fetal
programming in SAs comes from the PMNS cohort. Designed to assess how maternal
dietary practices affect fetal growth and diabetes, the PMNS recruited n = 2675 married
women of childbearing age from six villages near Pune, India between 1994 and 1996 [50].
In total, 797 women became pregnant and were followed up. Cultural differences between
maternal diet and health were identified by comparison with 668 white European mother-
infant pairs in Southampton, United Kingdom (UK).
Findings from the PMNS cohort show that SA newborns are, on average, 800 g lighter
and smaller in size (abdominal circumference deficit: SD score = −2.99; 95% CI: −3.09
to −2.89) but have similar visceral adiposity (VAT) (subscapular thickness deficit: SD
score = −0.53; 95% CI: −0.61 to 0.46) as white European newborns from the UK [50,53].
Such findings have highlighted the prevalence of the “thin-fat” phenotype in SA. Other
data from this cohort suggest that several genetic and environmental factors may contribute
to this phenotype. One such study, conducted using data from the PMNS, showed that
maternal malnutrition, specifically vitamin B12 deficiency, is significantly associated with
insulin resistance in their offspring at 6 years of age [54]. Moreover, findings from the
PMNS suggest that this insulin resistance in early childhood may be attributable to the
increased glucose (8.1 mmol/L vs. 7.5 mmol/L; P = 0.01) and insulin concentrations
(321 pmol/L vs. 289 pmol/L; P = 0.04) at birth in children who were born with low birth
weight compared to the ones who weighed >3.0 kg [55,56]. These data are consistent with
Barker’s hypothesis.
4.2. Findings from the South Asian Birth Cohort (START)
The South Asian Birth Cohort (START) study is a prospective birth cohort, established
in 2012. It is designed to evaluate the genetic and environmental risk factors that con-
tribute to metabolic disorders in SA women and their offspring [51]. This cohort study
recruited 1012 SA pregnant women between the ages of 18 and 40 years old during their
second trimester of pregnancy, with a sister cohort (with similar dimensions) developed in
India [51] (Supplementary Materials, Table S1).
Findings from this cohort suggest that the prevalence of GDM in the SA population of
Ontario, Canada is 36.3%, with maternal age, height, pre-pregnancy weight, diet quality,
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and family history of T2DM being identified as risk factors [44]. The cohort has also shown
that, like their Pune counterparts, SA newborns in Canada have significantly lower birth
weight (3.3 kg vs. 3.5 kg; P = 0.001) and higher skinfold thickness (11.7 mm vs. 10.6 mm;
P = 0.0001) compared to white European newborns, and this is associated with higher
maternal glucose and adiposity in SA women [57].
4.3. Findings from the Born in Bradford (BiB) Cohort
Another large international birth cohort outside the South Asian sub-continent study-
ing in-utero determinants of health, the Born in Bradford (BiB) Cohort was established in
2007. The BiB cohort aims to assess the environmental and genetic determinants of health
in SAs residing in Bradford, a northern UK city. The cohort recruited 12,453 women and
13,776 offspring, roughly 50% of whom are of Pakistani origin [52]. These women were
recruited from the Bradford Royal Infirmary between 2007–2010 at their 26th to 28th week
pregnancy visit.
Findings from the BiB cohort suggest that SA newborns have a lower mean birth
weight than white European newborns [58]. Moreover, data from the cohort has shown that
this low birth weight in SA newborns increases their risk for several morbidities in later life
such as an increased number of antibiotic, analgesic, and bronchodilator prescriptions used,
increased incidence of GP consultations, and emergency or elective hospital episodes [58].
5. Randomized Trials for GDM Prevention
Non-pharmacological trials to prevent GDM, including multidimensional coach-
ing, [56,57], intensive dietary counselling [59,60], and/or physical activity promotion [61],
are few, frequently non-randomized, and have heterogeneous designs and outcomes [62,63].
The current evidence does not suggest an optimal prevention strategy [64,65]. The com-
plexity of healthy behaviour interventions, the variability of adherence and delay before
introduction, and the heterogeneity of the maternal metabolic profile and diagnostic criteria
in GDM are design factors that contribute to discrepant results.
Diet-based interventions appear to demonstrate the most potential for GDM pre-
vention [66–68], as indicated by our network meta-analysis (21 trials during pregnancy;
n = 1865 women) [69]. We found that reduced glycaemic load and/or increased fiber
intake, with appropriate gestational weight-gain advice, contributed to improved fasting
glucose levels. In another meta-analysis (44 trials; n = 7278 women) [70] diet modification
alone (as assessed in three trials; n = 409 women) reduced GDM (relative risk [RR]: 0.68;
95% CI: 0.48 to 0.96). Following the publication of our review, there have been two other
important studies in the area. One randomized controlled trial in Ireland (n = 565) found
that exercise and nutrition with smartphone support did not reduce GDM in overweight
and obese women randomized at a mean gestational age of 15.3 weeks (RR: 1.1; 95% CI:
0.71 to 1.66) [71]. However, this study aimed to modify only one component of their diet
(i.e., a reduced glycaemic index). A second trial (Spain; n = 1000) found that a dietary
pattern, i.e., a Mediterranean diet supplemented with extra virgin olive oil and pistachios
reduced the incidence of GDM (RR: 0.73; 95% CI: 0.56 to 0.95) compared with standard
low-fat dietary advice [72]. Both studies enrolled mostly white European women. There
has been a trial of diet to prevent GDM in India (OR: 0.56; 95% CI: 0.36 to 0.86), but it is not
directly relevant to SAs that have emigrated, as the subjects were mainly women living in
slums in Mumbai [73]. These data highlight the importance of rigorously testing tailored
dietary interventions in a Canadian SA population.
6. Laying the Groundwork for Culturally Tailored Interventions: The Canadian Experience
Building on the START study, our research group has been actively investigating the
role of culturally tailored nutrition advice to provide SA women living in high-income
countries (HIC), such as Canada. Below, we describe some of these studies, both completed
and underway (Figure 1 and summarized in Supplementary Tables S1–S4).
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Barker hypothesis. The Barker hypothesis gave rise to birth cohort studies, which encouraged the
development of culturally tailored interventions and evaluations.
6.1. Qualitative Studies
6.1.1. The START Grandmothers’ Study
Grandmothers play important roles in supporting the family unit, especially in re-
lation to perinatal health and child-rearing. To better understand the health perceptions
of Canadian SA grandmothers, we used constructivist grounded theory to sample and
interview 17 SA grandmothers whose residences were in Ontario, Canada [74]. Interviews
were audio-recorded, transcribed verbatim, and coded/analyzed using a staged approach.
We found that many grandmothers believed that:
1. the pre-conception phase should emphasize the establishment of healthy habits
(nutrition, physical activity, and mental wellness);
2. the gestational period should encompass an enriched environment (positive relation-
ships, healthy routines, nutritional enhancement) and;
3. the postpartum period should focus on healing and restoration for the mother and
newborn child (self-care, bonding, rebuilding healthy habits).
Many of the grandmothers described these three phases as a cyclical relationship
where healing and restoration transitions to re-establishing healthy habits before a new
pregnancy is initiated. Grandmothers also took initiative in supporting their daughters
and/or daughters-in-law and actively encouraged perinatal health communication (Sup-
plementary Materials, Table S2).
6.1.2. DESI-GDM Qualitative Study
A UK study identified that many SA women experience pregnancy as a stressful
period and perceive exercise and diet restrictions to worsen specific symptoms, particularly
fatigue [75]. Notably, when confronted with a GDM diagnosis, pregnant SA women
were challenged in understanding their diagnosis and implementing responsive lifestyle
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modifications [76]. They seemed to maintain routine dietary habits and activities, including
those identified as traditional [76].
In the “Culturally-tailored personalized nutrition intervention in South Asian women
at risk of Gestational Diabetes Mellitus Qualitative Study” (DESI-GDM-Q), we conducted
interviews and focus groups with 10 pregnant or recently pregnant SA women to allow
women to foster open discussion and identify specific barriers to prescribed dietary advice
adherence. The interview schedule included questions designed to elicit beliefs about
optimal health behaviours, with a focus on diet and physical activity, for women before
and during pregnancy. Interviews and focus groups were also conducted with 11 health-
care providers who self-identified as counselling pregnant SA women in their respective
practices. These semi-structured interviews were conducted by female SA interviewers and
a female healthcare professional. The interviews were transcribed verbatim and translated
into English when necessary. We used an inductive process to analyze interviews and focus
group discussions [77]. Data collection and analysis occurred iteratively and concurrently,
and group discussions were held to reach an agreed point of saturation (Supplementary
Materials, Table S2).
The themes that emerged from the perspectives of SA pregnant women included:
(1) locus of control and (2) information-seeking, while the themes identified among health-
care providers included: (1) cultural competency and (2) clinic management and resources.
An overall theme shared by SA pregnant women and their healthcare providers was the
importance of the provider being competent in cultural awareness relevant to SA women.
The reflected intersection of the needs, perceptions, and experiences of pregnant
women and healthcare providers illuminate opportunities for the development of effective
and meaningful interventions. For example, consultations with diverse stakeholder groups
can guide the co-creation of a culturally tailored and evidence-based diet and physical
activity intervention to achieve normal levels of blood glucose during pregnancy. A cul-
turally tailored approach can provide program planners and researchers deeper insight
into end-user preferences for content, format, and preferred delivery method and help un-
derstand and overcome misconceptions while facilitating increased program participation.
A better understanding of these cultural underpinnings can support the development of
successful interventions tailored for pregnant SA women or their healthcare providers.
6.1.3. The HAPPY Study
In young children, poor diet quality and physical inactivity contribute to their risk of
excess body weight and metabolic syndrome (MetS). Weight excess, occurring in the first
years of life, tends to persist long-term. To better understand early-life family and home
environment contributors to this, we designed the study of Health Behaviour-Related
Perception, Attitudes, and Practice of Families with Young Children (HAPPY) to better
understand the experiences and perspectives of SA mothers in terms of healthy active living
lifestyles. This qualitative descriptive study used a thematic analysis approach to explore
salient themes arising from the data. In-depth, face-to-face interviews revealed important
barriers to and facilitators of healthy active living, as faced by young SA families living in
the Peel Region (Supplementary Materials, Table S2). Barriers to healthy eating included:
lack of time for engaging in healthy food preparation, lack of knowledge about healthy
eating, viewing healthy eating as a time-limited diet, spouses/children’s unhealthy eating
habits, and personal pressures to eat unhealthy foods; facilitators included: setting clear
goals, better access to fresh vegetables and fruits, clear arrangements for food preparation,
and engaging in vegetarian/vegan ways of eating. Barriers to physical activity included:
lack of time and energy to engage in exercise, competing priorities, lack of childcare, limited
access to relevant programs; facilitators included: viewing exercise as enjoyable and stress
releasing, use of tracking devices, and family support.
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6.2. Mixed Methods Research Studies
6.2.1. START WATCH
Many SA women can act as agents of change who can reinforce and reiterate healthy
active living messages (dietary, sleep, physical activity) within their social networks. We
designed the START “Women as Agents of Change” (START WATCH) study to better
understand the arrangement of social networks among young SA families living in Peel
Region. Our aim is to assess if structural supports (e.g., allied health professionals, pro-
grams in temples, schools, workplaces, etc.,) can empower SA women as agents of change.
We will conduct a social network analysis (SNA) and exploratory case study to compre-
hensively explore and describe how SA women in the Peel Region promote healthy active
living lifestyles within their families and social networks (Supplementary Materials, Ta-
ble S3). We will observe how messages are shared and use quantitative and qualitative
data collection to further explore how social networks function and influence members. To
supplement this analysis, we will conduct a community readiness model to assess the Peel
Region’s “stage of readiness.” This assessment will help predict how willing and prepared
a community is to address lifestyle change as it relates to NCD prevention.
6.2.2. SMART START
The SMART START study uses a mixed-methods multiple case study design to evalu-
ate an evidence-based, conceptually informed arts-based prenatal knowledge translation
(KT) intervention (a KT tool called ‘SMART START’) (Kandasamy et al., in progress). We
built upon the knowledge gaps introduced by the DESI-GDM qualitative study to develop
communication points tailored uniquely for patients and healthcare practitioners. The
‘SMART START’ KT tool, a tri-part multi-media toolkit consisting of an informational
video narrative, illustrated booklet, and summary material was evaluated against the
College of Family Physicians standard care “Prenatal Health Notes.” In partnership with
family practices, ‘SMART START’ was evaluated primarily for feasibility, acceptability,
and interest and secondarily for change in knowledge, attitudes, practices, and confidence
(Supplementary Materials, Table S3). It was demonstrated that healthy active living is a
topic area with a high degree of interest among pregnant people and their family physi-
cians; we showed feasibility regarding good, consistent recruitment (20 patients recruited
over a 7-month period) and retention (100% retention; reason for inability to follow-up
was due to miscarriage). Overall, pregnant patients valued the new prenatal information
they learned, improved some of their physical activity and dietary behaviours, and made
recommendations for improving future prenatal health communication.
7. Design and Piloting an RCT
Building upon our findings in START [44], which identified diet as a key modifiable
risk factor for GDM, DESI-GDM Qualitative, and SMART START [1,78,79], we have devel-
oped a dietary intervention program for South Asian pregnant women living in Canada
(Supplementary Materials, Table S4).
Our dietary intervention is focused on:
1. Providing personalized food recommendations that consider a woman’s current dietary
habits by identifying food choices and substitutions that will optimize her diet;
2. Providing dietary advice that is sensitive to religious and regional culinary practices;
3. Involving the household meal preparer, if this is not the participant herself, in the
coaching contacts;
4. Use of mobile health technology to support self-management and reduce the amount
of in-office time a healthcare practitioner spends on dietary counselling.
8. The DESI-GDM Randomized Controlled Trial
DESI-GDM is a 2-arm parallel RCT to assess the impact of a culturally tailored, person-
alized nutrition intervention on glycaemic response to an oral glucose load (as measured
by the area-under-the curve glucose) in high-risk pregnant SA women. As of 24 February
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2021, no trials in a SA population outside of India are registered with ClinicalTrials.gov
or the International Register of Clinical Trials other than our current and previous pilot
study [80].
8.1. The DESI-GDM RCT Pilot
The pilot study’s purpose was to assess the feasibility of recruitment, randomization,
intervention adherence, and participant retention. Success criteria defined for recruitment
was >6 participants/month. The clinical outcomes of interest were the glycaemic response
to an oral glucose load, incidence of GDM, and infant birth weight. Between 1 March 2019
and 31 July 2019, we recruited participants through family doctors, family health clinics,
OB/GYN clinics, and through posters in ethnic grocery stores, community centers, and
temples. To be eligible for this trial, women had to be of SA origin in the 2nd trimester of
pregnancy and possess two of the following risk factors: age > 29, low diet quality, a family
history of DM or prior gestational diabetes, or a pre-pregnancy BMI > 23.
We screened 34 participants, and 20 women of SA ancestry with risk factors for
gestational diabetes (GDM) were enrolled over 133 days, resulting in a recruitment rate
of 4.4 participants per month. The average age of participants was 30.6 ± 4.0 years, at
14.8 ± 2.1 weeks’ gestation, and they had lived in Canada for 8.6 ± 7.8 years. Half of the
women had a family history of diabetes; 15% had previous gestational diabetes, and 85%
had a BMI > 23. Their average diet quality score was 0.8 ± 0.9 out of 6, using a metric
that was associated with GDM in our SA birth cohort study [44]. Scores that approached 0
indicated low diet quality, and scores that approached 6 indicated high diet quality.
Each participant assigned to the intervention group met with a health coach via phone
or in-person to set and support the attainment of nutrition goals, 2–4 times, within the
context of energy-balance for recommended gestational weight gain and personal values
and preferences. Between 2 and 4 “SMART” goals were set according to the following
principles: (1) replacing traditional fried foods and meat with more vegetable protein
and raw and cooked vegetables; (2) reducing carbohydrate intake, for those who report
consumption of high quantities of refined carbohydrates; (3) improving carbohydrate
quality (replacing high glycaemic index, refined-grain SA foods with lower glycaemic
index, whole-grain SA foods (e.g., replacing white rice with parboiled rice, brown rice, or
legumes; replacing white flour paratha with whole wheat paratha); (4) reducing trans fats
(e.g., switching from commercial ghee to butter or vegetable oil); (5) scheduling regular
mealtimes, 3–4 h apart; (6) replacing fried, high-carbohydrate snacks (e.g., chaat or dahi
vada) with higher protein and fat snacks (such as nuts or full-fat dairy); (7) replacing
sweets and sugar-sweetened drinks (sweetened chai, soda pop, and juice) with water or
unsweetened tea and choosing fruits and other lower-sugar desserts over desserts high in
starch and sugar.
The control group participants were provided with paper copies and website links to
“The Sensible Guide to a Healthy Pregnancy”, which provides advice on healthy eating,
physical activity, and other lifestyle factors during pregnancy, plus additional materials
adapted specifically for the SA community.
All participants completed the OGTT visit, but only 12 (60%) completed the 75-g
OGTT as per study protocol. The remaining eight participants completed their general-
practitioner-prescribed the 50-g test.
The pilot study led us to make the following protocol changes for the main trial. First,
we found it difficult to identify and enrol participants who were <14 weeks pregnant. Only
three of our participants were <13 weeks. Thus, we increased our enrolment window,
allowing participants into the study up to 18 weeks’ gestation. Second, of the seven
participants who were due for their OGTT, three refused the 75-g OGTT and preferred to
follow their family doctor’s order for the 50-g glucose challenge. To avoid this problem in
the full trial, family physicians were more closely engaged in the referral and enrolment
process, based on an approach that we have used successfully in the START study. Referrals
were coordinated with the participant’s care provider such that the requisition for the 75-g
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OGTT and blood study replaced the test ordered by the provider. Fourth, our participants
responded well to the health coach, who was a multilingual SA woman, who could
incorporate culturally sensitive dietary information. Though all participants were fluent
in English, some words or concepts were better expressed in a SA language, and we will
work to match this characteristic in the full trial.
8.2. The DESI-GDM RCT
In the DESI-GDM trial, pregnant SA women without known diabetes will be enrolled
early in the second trimester. This avoids including women experiencing peak nausea
early in pregnancy, and it is past the highest period of risk for spontaneous abortion.
Eligible participants will be pregnant women of SA ancestry at gestational weeks 14–18
with a singleton pregnancy; and ≥2 of the following GDM risk factors: age > 29, low diet
quality (assessed with a short diet screener [44]), a family history of DM, GDM during a
previous pregnancy, or a pre-pregnancy BMI ≥ 23 [44]. We will exclude women with pre-
existing type 1 or type 2 diabetes; high blood pressure (≥140 mmHg systolic or ≥90 mmHg
diastolic); a poor understanding of English (93% of Canadian SA women in the National
Household Survey could conduct a conversation in one or both official languages [1]);
those unwilling to modify their diet, based on a screening question; those at high risk
of adverse pregnancy outcomes other than GDM (e.g., twins or higher-order multiples,
use of fertility treatment, preexisting hypertension, history of placenta previa, or pre-term
delivery); or who are enrolled in another study (Supplementary Materials, Table S4).
A personalized nutrition plan will be developed for each woman by a culturally
congruent dietitian. This plan will respect faith-based food choices and regional preferences.
The plan will be delivered by a culturally congruent health coach and consider baseline
dietary intake, energy-balance for recommended gestational weight gain, personal values,
and preferences, through setting 2–4 “SMART” goals (as described above). Our nutrition
and behaviour change experts have developed text messages that support 11 categories
of nutrition goals, targeted to address eating behaviours identified by participants in our
qualitative study, designed to optimize energy balance for weight gain and improve dietary
quality. Control group participants will be provided with paper copies of and website links
to “The Sensible Guide to a Healthy Pregnancy”, which provides advice on healthy eating,
physical activity, and other lifestyle factors during pregnancy, plus additional materials
adapted specifically for the SA community. Healthcare providers in the Peel Region use
these tools routinely (Diabetes Canada: https://bit.ly/2m8r2tT, accessed on 20 August
2021, or Heart & Stroke: https://bit.ly/2lDubl7, accessed on 20 August 2021). Participants
in both control and intervention groups receive at least 1 text message every week. We
developed a roster of text messages to encourage walking and healthy eating, which were
well accepted by participants in our pilot study.
Text messages to reinforce individual nutrition goals for the intervention group will be
sent weekly. We will encourage participants to respond and engage in two-way dialogue
with the health coach. This strategy has better uptake than impersonal one-way messages
at predetermined times that do not permit confirmation of receipt or feedback [81,82].
The intervention group will receive at least two text messages/week at the times of day
requested by the participant: one or more tailored diet text messages and a message that
provides one of six walking tips. Coaching calls to the intervention group will be made
post-baseline weeks 2, 4, 6, 8, 10, 12, 14, and 16 (bi-weekly up to OGTT). At each scheduled
contact, intervention participants will review the agreed-upon diet goals, and assess, on a
Likert scale, how often they were able to meet them (ranging from “never” through “all
of the time”); the coach will work with the participant to overcome barriers using our
brief action planning guide. In our pilot study, health-coaching calls lasted 15–20 min.
The individualized nutrition plan will be modified during follow-up by the health coach,
according to feedback from the participant, and through a review of the dietary information
collected.
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The primary clinical outcome of this trial is the glucose area under the curve (glucose
AUC). As a measure of glycaemic response, glucose AUC is a continuous measure of the
response to a 75-g OGTT that accounts for variations in fasting plasma glucose levels
between individuals. It is calculated by the trapezoidal method using the fasting, 1-h, and
2-h glucose [83]. The AUC is superior to a single measure, which, although convenient
for diagnosis and treatment, may not provide complete information regarding the pro-
cessing of plasma glucose after a load [84]. The secondary outcome is GDM, classified
using the cut-offs derived in the BiB cohort: fasting glucose ≥5.2 mmol/L or 2-h post-
load ≥7.2 mmol/L [85]. These cut-offs were associated with infant birth weight >90th
percentile for gestational age and adiposity (sum of skinfold measurements [SSF] >90th
percentile for gestational age) in this cohort [85]. Current clinical cutoffs for the 75-g OGTT
used to diagnose GDM in the general population are: fasting glucose ≥5.3 mmol/L, 1-h
≥10.6 mmol/L, or 2-h ≥9.0 mmol/L [86]. In Peel, pregnant women usually undergo a 50-g
glucose challenge at 24–28 weeks, with a 1-h value ≥7.8 mmol/L being an indication for a
75-g OGTT [87].
We have selected the 75-g OGTT because:
1. it was used to establish SA-specific diagnostic criteria for GDM, and thus our out-
comes will be directly comparable [85];
2. it avoids the high false negative rate of the 50-g GCT among SAs [51,88];
3. one-step screening has the potential for long-term cost savings [89–91];
4. Diabetes Canada recognizes that the one-step strategy can identify a subset of women
who would not otherwise be identified as having GDM and who may benefit with
regards to certain perinatal outcomes [86].
We will co-ordinate with the healthcare provider to ensure participants receive the
75-g OGTT between 24–28 weeks, avoiding the two-step screen. A study endocrinologist
will review the OGTT results and send a letter to the participant’s provider communicating
the result, to ensure continuity of care and appropriate management. We will assess the
sensitivity and specificity of the BiB definition against the IASPSG or WHO criteria. To
evaluate safety outcomes, we measure maternal blood pressure at baseline and the OGTT
visit and note any pregnancy complications at coaching contacts.
With 95 participants per group, and an expected 10% loss-to-follow-up, we will have
≈86 participants per group, which will provide 90% power to detect at least a 15% between-
group difference in AUC glucose, assuming 70% adherence to the intervention (i.e., goal
setting, health coach contacts, tracking) and SD of AUC glucose = 173 mmol/min [44].
A change of at least this magnitude has been observed in trials of fibre supplements [89],
high-protein [92], and high-fat diets [93]. We will have 80% power to detect a 61% relative
risk reduction in GDM. An effect of this magnitude is unlikely, so we will look to see if
GDM is lower in the intervention. Failure to observe substantial impact on AUC glucose
(i.e., <10% reduction) with no signal of benefit for GDM (i.e., an OR between 0.9 and 1.1) or
a signal of harm (OR > 1.1) with high intervention fidelity will suggest that a larger trial
primarily powered to detect differences in GDM is not warranted.
9. Conclusions
In summary, maternal lifestyle factors influence the in utero environment of devel-
oping fetuses, which in turn influences the health outcome of newborns. A considerable
amount of data exists demonstrating the early life risk factors for CVD among SAs. Trials
of diet and behaviour modification to reduce gestational glycaemia in pregnant SA women
in Canada are needed because:
1. SAs are among the fasting growing and largest non-white minority group in Canada [1,2];
2. SAs are a high risk population for GDM, T2DM, and CVD [94];
3. GDM is a risk factor for future T2DM and CVD in both mother and offspring (pro-
ducing two high-risk individuals) [36–42];
4. There have been no prior or planned RCTs of GDM prevention in SAs living in
high-income countries as of 1 May 2021 other than our pilot study [80];
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5. Pregnancy is an ideal time to intervene with a diet intervention [95].
We have designed an RCT that addresses key aspects shown to improve the effective-
ness of lifestyle interventions during pregnancy: we target a high-risk population, initiate
the intervention early, provide the correct intensity and frequency of contact, and manage
gestational weight gain [96]. Groundwork for the trial’s success includes our cohort study
identifying diet as a modifiable risk factor for GDM in SAs [44], a qualitative study to
understand the unmet needs of the population [75], pilot data showing that participant
recruitment and retention is feasible and that the delivery of the intervention is acceptable,
and strong partnerships with healthcare providers and public health in Peel, a region with
a high number of SAs. Our trial will assess whether diet intervention reduces gestational
glycaemia. The intervention targets two at-risk individuals: mother and infant, “break-
ing the cycle” of maternal gestational dysglycaemia, excess infant adiposity and insulin
resistance, and CVD in both mother and baby.
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